Insider trade

CEO sold ~$205K of UNH shares in the open market

Traded Aug 5, 2026 · Filed Aug 7, 2026

UnitedHealthUNH

~$205K
Reported value · 500 sh @ $410.00: 16K
Holds after · shares reported: -11.5%
stock since the trade · S&P 500 -0.8%, $412.75 → $365.20 on Oct 1

Why it stands out

The boss of UnitedHealth sold $205K of UnitedHealth shares. Nobody planned it ahead of time.

Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell

View the official recordSEC Form 4 — Statement of Changes in Beneficial Ownership

All the details

Dates, kept separate

Transaction date: Aug 5, 2026
Reporting period: Not applicable
Filed with the SEC: Aug 7, 2026

CEO$100K–$500K

Context

Classification

open market sale

Code S — open-market or private sale

Absolute commitment

~$205,000

Shares × reported transaction price

Timing vs results

20 days after results of Jul 16, 2026

Results dates are the company's own 8-K (Item 2.02). Many companies only let insiders trade in a window after results

Price at the time

Closed at $412.75 on Aug 5, 2026, 69% above its 52-week low and 5% below its high, little changed over the previous 30 trading days

52-week range $244.67 (Aug 7, 2025) to $436.35 (Jul 21, 2026), 88% of the way up, from 251 adjusted closes. 30 trading days earlier: $409.25 on Jun 23, 2026. Describes the past only, not a forecast

Planned / mechanical clue

None found in footnotes

Only flagged when a footnote says so; never inferred

Securities lawsuit open at the trade date

A securities lawsuit naming the company as a defendant was filed on Mar 20, 2026 in the U.S. District Court, District of Columbia. A filing is an allegation, not a finding.

2 such cases were open. FONDS DES MISSIONS v. UNITEDHEALTH GROUP INCORPORATED, docket 1:26-cv-00970, via CourtListener (court records). Nature of suit 850, company named as first defendant